Skip to main content

Table 1 Baseline demographics and clinical features of patients in study

From: Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms

Patient demographics and clinical features

 

Bipolar diagnosis, n (%)

 

 Bipolar I

6 (30)

 Bipolar II

14 (70)

Females, n (%)

10 (50)

Caucasians, n (%)

20 (100)

Age (years), mean (SD)

47.9 (12.4)

MADRS, mean (SD)

20.5 (7.8)

 Range

6 to 36

YMRS, mean (SD)

7.5 (6.5)

CGI-S, mean (SD)

4.2 (0.7)

 Range

2 to 5

Weight (kg), mean (SD)

89.6 (19.6)

Starting dose (mg), mean (SD)

8.8 (3.2)

 Range

5 to 15

Endpoint dose (mg), mean (SD)

11.5 (4.6)

 Range

5 to 20